|
(3S,4S,5S,10S,13R)-4,10,13-Trimethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,4,5,6,7,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol |
|
CHEBI:181919 |
|
This entity has been manually annotated by a third party.
|
|
MetaboLights
|
|
|
|
Molfile
XML
SDF
|
|
|
|
InChI=1S/C28H46O/c1-18(2)8-7-9-19(3)22-12-13-24-21-10-11-23-20(4)26(29)15-17-28(23,6)25(21)14-16-27(22,24)5/h8,19-20,22-24,26,29H,7,9-17H2,1-6H3/t19-,20+,22?,23+,24?,26+,27-,28+/m1/s1 |
FOUJWBXBKVVHCJ-LVELUJLUSA-N |
O[C@@H]1[C@H]([C@]2([C@@](C3=C(C4[C@@](C(CC4)[C@@H](CCC=C(C)C)C)(CC3)C)CC2)(CC1)C)[H])C |
|
Outgoing
|
(3S,4S,5S,10S,13R)-4,10,13-Trimethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,4,5,6,7,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
(CHEBI:181919)
is a
cholestanoid
(CHEBI:50401)
|
|
(3S,4S,5S,10S,13R)-4,10,13-trimethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,4,5,6,7,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
|
|